NOVOMIX 30 NOVORAPID FLEXPEN

Dose: 0.5 to 0.8 units/kg/day
Single Dose: 0.65 (0.65)
Frequency: As recommended.
Route: SC
Instructions: For Diabetes Mellitus Type I: Initial dose

.

Insulin Aspart is contraindicated in conditions like Hypoglycaemia,Hypersensitivity to any component of product.

The symptomatic adverse reactions produced by Insulin Aspart are more or less tolerable and if they become severe, they can be treated symptomatically, these include Local reactions, Fat hypertrophy at injection site, Swelling of feet.

Insulin Aspart is primarily indicated in conditions like Diabetes mellitus.

Insulin Aspart is known to interact with other drugs, the details of drug interactions is as follows:DrugDetailsSeverityOnsetManagementDiazoxideDiazoxide antagonises hypoglycaemic effect of antidiabetics (insulin).Metformin (HCl)Metformin potentiate the hypoglycemic effect of insulin by increasing cellular mechanism controlled by insulin.ModerateClosely monitor the development of hypoglycaemia in patient. These interactions are sometimes beneficial and sometimes may pose threats to life. Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

Monitoring of blood and urine glucose

If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

The human insulin analogues, insulin lispro and insulin aspart, have a faster onset of action and shorter duration of action than soluble insulin; as a result, compared to soluble insulin, fasting and preprandial blood-glucose concentration is a little higher, postprandial blood-glucose concentration is a little lower, and hypoglycaemia occurs slightly less frequently. Insulin aspart should be used with caution in patients with renal impairment (May need dose reduction).